Astrazeneca Pharma India Ltd.
₹8,609.5
-86 (-1%)
ASTRAZEN Share Price
As on May 20, 2026
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap₹ 21,480 Cr
P/E Ratio185.97
Dividend Yield0.19 %
Trendline Performance
We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.
Unlock Stock of the Month
T&C*
Company Information
Market Insights
Open8,700
High8,815
NSE SymbolASTRAZEN
Close8,609.5
Low8,580
BSE Symbol506820
Previous Years High/Low
1 Year High10,691
3 Year High10,691
5 Year High10,691
1 Year Low7,551.5
3 Year Low3,125
5 Year Low2,445.7
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 8,527.8 | Bullish |
| 10-DMA | 8,495.65 | Bullish |
| 20-DMA | 8,431.5 | Bullish |
| 50-DMA | 8,370.04 | Bullish |
| 100-DMA | 8,519.84 | Bullish |
| 200-DMA | 8,771.04 | Bearish |
Historical Performance
1 Year
8.7%
3 Years
168.9%
5 Years
128.4%
10 Years
693%
Shareholding Pattern
Values Analysis
Loading chart...
Profit & Loss
Below figures are in Rs. Crores
Compounded Sales Growth
10 Years:27.1
5 Years:15.6
3 Years:16.3
TTM:5.8
Compounded Profit Growth
10 Years:14
5 Years:9.9
3 Years:13.4
TTM:-6.4
Stock Price CAGR
10 Years:23
5 Years:17.9
3 Years:39.1
TTM:8.4
Return on Equity
10 Years:2.1
5 Years:37.3
3 Years:39.7
last year:46.3
Quarterly Results
Below figures are in Rs. Crores
| Particulars | Sep-2024 | Dec-2024 | Mar-2025 | Jul-2025 | Sep-2025 |
|---|---|---|---|---|---|
| Sales | 1,70,754 | 1,35,936 | 1,28,552 | 1,22,189 | 1,05,161 |
| Expenses | 63,042 | 56,557 | 52,457 | 45,459 | 34,856 |
| Operating Profit | 1,07,712 | 79,379 | 76,096 | 76,730 | 70,304 |
| OPM % | 63% | 58% | 59% | 63% | 67% |
| Other Income | 33,912 | 31,759 | 27,333 | 24,879 | 18,947 |
| Interest | 77,780 | 58,584 | 59,248 | 62,137 | 53,713 |
| Depreciation | 2,345 | 1,681 | 1,385 | 1,277 | 1,221 |
| Profit Before Tax | 61,498 | 50,873 | 42,796 | 38,195 | 34,318 |
| Tax % | 25% | 25% | 26% | 29% | 35% |
| Net Profit | 46,149 | 38,151 | 31,857 | 27,296 | 22,446 |
| EPS in Rs | 83 | 69 | 58 | 50 | 42 |
Balance Sheet
Below figures are in Rs. Crores
0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
- The stock has a high PE of 185.97, indicating expensive valuation or elevated growth expectations.
- Over the last three years, the stock delivered a strong 3-year price CAGR of 39.4%, indicating sustained price appreciation.
- The stock carries a low beta of 0.4, suggesting lower volatility than the broader market.
- In the last financial year, the company reported an EBITDA of ₹2946 million, reflecting positive operating performance.
- In the previous financial year, the company generated revenue of ₹17163 million, indicating a large and established business.
Investment Calculator
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1084251.6
No. of Shares: 126 (Approx)
Performance:8.4%
P/L: ₹84251.6
NIFTY Performance: -4.7%
1 day Top Gainers
1 Day Top Losers
| Symbol | Change% |
|---|---|
| PIIND | 2901.2(-7%) |
| MAPMYINDIA | 911.95(-6%) |
| ZEEL | 82.95(-5%) |
| BASF | 3623.5(-5%) |
| MANYAVAR | 415.05(-4%) |
| BALRAMCHIN | 530.75(-4%) |
| M&MFIN | 309(-3%) |
| AFCONS | 305.4(-3%) |
Top Performing Stocks from the same sector
Get Your Portfolio Reviewed
Latest News
Stay Updated with Our Market Newsletters
